Q1 2025 Earnings Call Transcript May 12, 2025 Neumora Therapeutics, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.42 EPS, expectations were $-0.4. Operator: Ladies and ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...